Myeloma Investment Fund

The Myeloma Investment Fund (MIF) is a venture philanthropy fund that invests in promising companies, clinical assets, and technologies in oncology to drive the development of new therapies for multiple myeloma. The MIF collaborates closely with portfolio companies to help them advance multiple myeloma research. This evergreen fund is supported entirely by philanthropy; all profits will be reinvested back into research for more effective treatments until there is a cure for every patient. We are the first and only mission-driven venture philanthropy fund focused on accelerating a cure for multiple myeloma. Myeloma Investment Fund was founded in 2019.